{"protocolSection": {"identificationModule": {"nctId": "NCT02808585", "orgStudyIdInfo": {"id": "PB1046-PT-CL-0003-P1"}, "organization": {"fullName": "PhaseBio Pharmaceuticals Inc.", "class": "INDUSTRY"}, "briefTitle": "Study to Assess the Safety, Tolerability and PK/PD After 4 Weekly SC Injections of PB1046 in Subjects With Stable HFrEF", "officialTitle": "Randomized, Double-blind, Placebo-controlled, Multiple-Dose, Study to Assess the Safety, Tolerability, PK and PD After 4 Weeks of Once Weekly Sc. Inj. of PB1046 in Adults With Stable HFrEF, and in Subjects With Cardiac Dysfunction Secondary to DMD"}, "statusModule": {"statusVerifiedDate": "2022-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2016-06", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2017-12-06", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-12-06", "type": "ACTUAL"}, "studyFirstSubmitDate": "2016-06-08", "studyFirstSubmitQcDate": "2016-06-16", "studyFirstPostDateStruct": {"date": "2016-06-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2022-04-20", "resultsFirstSubmitQcDate": "2022-06-20", "resultsFirstPostDateStruct": {"date": "2022-07-14", "type": "ACTUAL"}, "dispFirstSubmitDate": "2019-03-18", "dispFirstSubmitQcDate": "2019-03-25", "dispFirstPostDateStruct": {"date": "2019-03-29", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2022-06-20", "lastUpdatePostDateStruct": {"date": "2022-07-14", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "PhaseBio Pharmaceuticals Inc.", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "This study will be a sequential multiple-dose escalation study that will enroll (randomize and dose) approximately 28 subjects in four cohorts consisting of 3 active and 1 placebo in Cohort 1 and 6 active and 2 placebo in subsequent cohorts. Randomized subjects will receive a fixed weekly dose of study drug or placebo for a 4 week dosing period.", "detailedDescription": "Qualifying subjects will have a diagnosis of NYHA Class II or III heart failure with a reduced ejection fraction (HFrEF), be in stable condition, and be taking clinician-directed appropriate pharmacological therapy (e.g., angiotensin converting enzyme inhibitors, angiotensin receptor blockers or an evidence based beta blocker) for heart failure at stable doses (with the exception of diuretics) for at least 1 month prior to screening.\n\nDuring the period between screening and randomization (planned first dose), the study subject will remain on stable pharmacological therapy for heart failure. Also the study subject will be in stable health with no hospitalizations or clinically significant acute illnesses between screening and randomization that would put the subject at increased risk for study participation.\n\nRandomized subjects will receive a fixed weekly dose of study drug or placebo for a 4 week dosing period. Dose escalation in subsequent cohorts will continue if the safety and pharmacokinetic profile are deemed acceptable as assessed by the Study Review Committee."}, "conditionsModule": {"conditions": ["Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "SEQUENTIAL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 29, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "PB1046 Injection, 0.2 mg/kg", "type": "EXPERIMENTAL", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg", "interventionNames": ["Drug: PB1046 Injection"]}, {"label": "PB1046 Injection, 0.4 mg/kg", "type": "EXPERIMENTAL", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg", "interventionNames": ["Drug: PB1046 Injection"]}, {"label": "PB1046 Injection, 0.6 mg/kg", "type": "EXPERIMENTAL", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg", "interventionNames": ["Drug: PB1046 Injection"]}, {"label": "PB1046 Injection, 1.2 mg/kg", "type": "EXPERIMENTAL", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg", "interventionNames": ["Drug: PB1046 Injection"]}, {"label": "Placebo Comparator", "type": "PLACEBO_COMPARATOR", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection", "interventionNames": ["Drug: Placebo Injection"]}], "interventions": [{"type": "DRUG", "name": "PB1046 Injection", "description": "Four weekly subcutaneous injections of PB1046.", "armGroupLabels": ["PB1046 Injection, 0.2 mg/kg", "PB1046 Injection, 0.4 mg/kg", "PB1046 Injection, 0.6 mg/kg", "PB1046 Injection, 1.2 mg/kg"], "otherNames": ["PB1046"]}, {"type": "DRUG", "name": "Placebo Injection", "description": "Four weekly subcutaneous injections of placebo.", "armGroupLabels": ["Placebo Comparator"], "otherNames": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Telemetry", "description": "Number of participants with rhythm abnormalities as assessed by continuous mobile telemetry monitoring.", "timeFrame": "Up to six weeks starting 7 to 10 days before first dose."}, {"measure": "12-Lead ECG Assessment - Incidence of Clinically Significant Findings", "description": "Number of participants with a clinically significant change from baseline in 12-Lead ECG and presence of rhythm abnormalities and relationship to exposure of PB1046 compared to placebo", "timeFrame": "Seven weeks starting the first week of dosing."}, {"measure": "12-Lead ECG - Categorical Analysis of QT/QTc Interval - Participants With Clinically Significant Findings", "description": "Number of participants with a clinically significant change from baseline in 12-Lead ECG and presence or absence of rhythm abnormalities and relationship to exposure of PB1046 compared to placebo", "timeFrame": "Seven weeks starting the first week of dosing."}, {"measure": "Laboratory Parameters - Serum Chemistry - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (serum chemistry) and the relationship to PB1046 compared to placebo", "timeFrame": "Eight weeks starting one week before first dose."}, {"measure": "Laboratory Parameters - Hematology - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (hematology) and the relationship to PB1046 compared to placebo", "timeFrame": "Eight weeks starting one week before first dose."}, {"measure": "Laboratory Parameters - Urinalysis - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (urinalysis) and the relationship to PB1046 compared to placebo", "timeFrame": "Eight weeks starting one week before first dose."}, {"measure": "Laboratory Parameters - eGFR", "description": "Changes from baseline in laboratory parameters (eGFR) and the relationship to PB1046 compared to placebo.\n\nCalculated using Chronic Kidney Disease Epidemiology Collaboration Equation (CKD-EPI)", "timeFrame": "Baseline, Week 2, 3, 4, 5 and 8."}, {"measure": "Laboratory Parameters - Lipid Profile - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (lipid profile) and the relationship to PB1046 compared to placebo", "timeFrame": "Eight weeks starting one week before first dose (Baseline and at Week 8)."}, {"measure": "Vital Signs - Systolic Blood Pressure", "description": "Changes from baseline in vital signs (systolic blood pressure) and the relationship to PB1046 compared to placebo.", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49."}, {"measure": "Vital Signs - Heart Rate", "description": "Changes from baseline in vital signs (heart rate) and the relationship to PB1046 compared to placebo.", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49."}, {"measure": "Vital Signs - Temperature", "description": "Changes from baseline in vital signs (temperature) and the relationship to PB1046 compared to placebo.", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49."}, {"measure": "Vital Signs - Respiratory Rate", "description": "Changes from baseline in vital signs (respiratory rate) and the relationship to PB1046 compared to placebo.", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49."}, {"measure": "Vital Signs - Diastolic Blood Pressure", "description": "Changes from baseline in vital signs (systolic blood pressure) and the relationship to PB1046 compared to placebo.", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49."}], "secondaryOutcomes": [{"measure": "Pharmacokinetic Profile - Area Under the Curve Over the Dosing Interval [AUC(0-t)]", "description": "Comparison of dose exposures \\[AUC(0-t)\\] during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Maximum Serum Concentration (Cmax)", "description": "Comparison of dose exposures (Cmax) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Time to Cmax (Tmax)", "description": "Comparison of dose exposures (Tmax) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Elimination Rate Constant (Lambda z)", "description": "Comparison of dose exposures (lambda z) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Elimination Half-life (t\u00bd)", "description": "Comparison of dose exposures (t\u00bd) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Clearance (CL/F), Uncorrected for Bioavailability", "description": "Comparison of dose exposures (CL/F) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Pharmacokinetic Profile - Volume of Distribution (Vz/F), Uncorrected for Bioavailability (F)", "description": "Comparison of dose exposures (Vz/F) during once weekly administration of various doses of PB1046", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31."}, {"measure": "Immunogenicity", "description": "Number of participants reporting positive immunogenicity (four-fold increase of pre-dose titer)", "timeFrame": "Eleven weeks starting the first week of dosing."}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Willing and able to sign a written informed consent and follow all study-related procedures,\n* Male subjects and female subjects of reproductive or childbearing potential must practice effective contraception during the study and be willing and able to continue contraception for 30 days after their last dose of study drug,\n* Body mass index \u2265 18 kg/m2 and \u2264 45 kg/m2,\n* Receipt of stable pharmacological therapy(ies) for heart failure for a minimum of 1 month prior to screening and between screening and randomization and are in stable clinical condition,\n* NYHA Class II or III heart failure diagnosis (ischemic or non-ischemic confirmed by medical history) at least 6 months prior to screening,\n* Stable HF defined as no hospitalizations for cardiac related issues within the previous 3 months prior to the screening visit or between screening and randomization,\n* A screening or historical Left Ventricular Ejection Fraction \u2264 40% by centralized reading of 2-D echocardiography,\n* Screening hemoglobin \u2265 9.0 g/dL secondary to the volume of blood to be collected during the study period,\n* Willing and able to return to the study unit for specified study visits, and be able to self-monitor blood pressure while at home,\n* Live and work in an area with reliable cellular services (e.g., Sprint\u00ae) for real time transmission of telemetry data to the core laboratory.\n\nExclusion Criteria:\n\n* Have previously received PB1046 or have a known allergy to the study drug or any of its components,\n* Participating in any other study and have received any other investigational medication or device within 30 days prior to screening or are taking part in a non-medication study which, in the opinion of the Investigator, would interfere with study compliance or outcome assessments,\n* Diagnosed with acute coronary syndrome (ACS) or an acute myocardial infarction (MI) within 3 months of screening,\n* Canadian Cardiovascular Society (CCS) Class III or IV angina necessitating frequent use of as needed short acting nitroglycerin,\n* Cardiac surgery or valvuloplasty within 3 months prior to screening,\n* Cerebrovascular accident or transient ischemic attack within 3 months prior to screening,\n* Sustained systolic blood pressure (SBP) \\< 110 mmHg and/or diastolic blood pressure (DBP) \\< 50 mmHg (confirmed by a duplicate seated reading) on at least 3 consecutive readings (self-monitored or office) prior to randomization or overt symptomatic hypotension,\n* Sustained resting heart rate \\>100 beats per minute (BPM) at screening (V1) or prior to randomization,\n* History or evidence of clinically significant arrhythmias (uncontrolled by drug therapy or use of an implantable defibrillator), long QT syndrome or evidence of QT prolongation demonstrating QTcF \\> 460 ms prior to randomization (Subjects with QTcF \\>460 ms due to electronic pacing by an implanted pacemaker/ICD device may be enrolled),\n* Clinically significant renal dysfunction as measured by the estimated glomerular filtration rate (eGFR) of \\< 40 mL/min/1.73m2 as calculated by the CKD-EPI creatinine-cystatin C equation at screening, or a clinically significant change in renal function between screening and baseline,\n* Clinically significant liver dysfunction as measured by: alanine aminotransferase \\>3.0 \u00d7 the upper limit of normal (ULN), aspartate aminotransferase \\>3.0 \u00d7 the ULN, or serum bilirubin \u2265 1.6 mg/dL at screening, or a clinically significant change in liver function between screening and baseline,\n* Pregnant or lactating female subjects,\n* Known history of or active alcohol abuse or use of illicit drugs within 1 year prior to randomization,\n* Positive screening for human immunodeficiency virus antibodies, hepatitis B surface antigen, or hepatitis C virus antibodies,\n* Any major surgical procedure within 1 month prior to screening or planned surgical procedure during the study period,\n* Other medical or psychiatric condition which, in the opinion of the Investigator, would place the subject at increased risk or would preclude obtaining voluntary consent/assent or would confound the secondary objectives of study.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"locations": [{"facility": "Pinnacle Research Group, LLC", "city": "Anniston", "state": "Alabama", "zip": "36207", "country": "United States", "geoPoint": {"lat": 33.65983, "lon": -85.83163}}, {"facility": "Phoenix Medical Research", "city": "Peoria", "state": "Arizona", "zip": "85381", "country": "United States", "geoPoint": {"lat": 33.5806, "lon": -112.23738}}, {"facility": "Cardiology Associates Research Company", "city": "Daytona Beach", "state": "Florida", "zip": "32117", "country": "United States", "geoPoint": {"lat": 29.21081, "lon": -81.02283}}, {"facility": "Revivial Research", "city": "Miami", "state": "Florida", "zip": "33173", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "North Dallas Research Associates", "city": "McKinney", "state": "Texas", "zip": "75069", "country": "United States", "geoPoint": {"lat": 33.19762, "lon": -96.61527}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "FG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "FG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "FG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "FG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "7"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "7"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "6"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "7"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "groups": [{"id": "BG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "BG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "BG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "BG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "BG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}, {"id": "BG005", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "7"}, {"groupId": "BG005", "value": "29"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "60.7", "spread": "13.01"}, {"groupId": "BG001", "value": "69.7", "spread": "10.89"}, {"groupId": "BG002", "value": "67.6", "spread": "11.27"}, {"groupId": "BG003", "value": "64.3", "spread": "4.03"}, {"groupId": "BG004", "value": "65", "spread": "8.41"}, {"groupId": "BG005", "value": "66.0", "spread": "9.18"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "2"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "8"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "4"}, {"groupId": "BG004", "value": "6"}, {"groupId": "BG005", "value": "21"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "1"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "1"}, {"groupId": "BG005", "value": "3"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "5"}, {"groupId": "BG002", "value": "6"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "6"}, {"groupId": "BG005", "value": "25"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}, {"groupId": "BG004", "value": "0"}, {"groupId": "BG005", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "6"}, {"groupId": "BG004", "value": "7"}, {"groupId": "BG005", "value": "29"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Telemetry", "description": "Number of participants with rhythm abnormalities as assessed by continuous mobile telemetry monitoring.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Up to six weeks starting 7 to 10 days before first dose.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "12-Lead ECG Assessment - Incidence of Clinically Significant Findings", "description": "Number of participants with a clinically significant change from baseline in 12-Lead ECG and presence of rhythm abnormalities and relationship to exposure of PB1046 compared to placebo", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Seven weeks starting the first week of dosing.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator, 0.9% NaCl.\n\nPB1046 Injection: Four weekly subcutaneous injections of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "12-Lead ECG - Categorical Analysis of QT/QTc Interval - Participants With Clinically Significant Findings", "description": "Number of participants with a clinically significant change from baseline in 12-Lead ECG and presence or absence of rhythm abnormalities and relationship to exposure of PB1046 compared to placebo", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Seven weeks starting the first week of dosing.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator, 0.9% NaCl.\n\nPB1046 Injection: Four weekly subcutaneous injections of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Laboratory Parameters - Serum Chemistry - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (serum chemistry) and the relationship to PB1046 compared to placebo", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Eight weeks starting one week before first dose.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator, 0.9% NaCl.\n\nPB1046 Injection: Four weekly subcutaneous injections of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Laboratory Parameters - Hematology - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (hematology) and the relationship to PB1046 compared to placebo", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Eight weeks starting one week before first dose.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Laboratory Parameters - Urinalysis - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (urinalysis) and the relationship to PB1046 compared to placebo", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Eight weeks starting one week before first dose.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator, 0.9% NaCl.\n\nPB1046 Injection: Four weekly subcutaneous injections of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Laboratory Parameters - eGFR", "description": "Changes from baseline in laboratory parameters (eGFR) and the relationship to PB1046 compared to placebo.\n\nCalculated using Chronic Kidney Disease Epidemiology Collaboration Equation (CKD-EPI)", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. One subject at 0.6 mg/kg dose missed sample collection and was excluded from analysis.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL/min/1.73m^2", "timeFrame": "Baseline, Week 2, 3, 4, 5 and 8.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Week 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.04", "spread": "4.00"}, {"groupId": "OG001", "value": "2.2", "spread": "11.41"}, {"groupId": "OG002", "value": "-2.9", "spread": "13.23"}, {"groupId": "OG003", "value": "1.3", "spread": "7.39"}, {"groupId": "OG004", "value": "-4.6", "spread": "5.88"}]}]}, {"title": "Week 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "5.77"}, {"groupId": "OG001", "value": "0.2", "spread": "10.72"}, {"groupId": "OG002", "value": "2.3", "spread": "11.40"}, {"groupId": "OG003", "value": "1.8", "spread": "7.57"}, {"groupId": "OG004", "value": "-4.6", "spread": "5.19"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "2.65"}, {"groupId": "OG001", "value": "-1.3", "spread": "7.97"}, {"groupId": "OG002", "value": "-1.4", "spread": "4.12"}, {"groupId": "OG003", "value": "5.8", "spread": "9.55"}, {"groupId": "OG004", "value": "-6.6", "spread": "6.13"}]}]}, {"title": "Week 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.3", "spread": "6.66"}, {"groupId": "OG001", "value": "-0.7", "spread": "7.26"}, {"groupId": "OG002", "value": "-2.2", "spread": "13.29"}, {"groupId": "OG003", "value": "9.3", "spread": "7.93"}, {"groupId": "OG004", "value": "-2.3", "spread": "6.63"}]}]}, {"title": "Week 8", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.3", "spread": "8.62"}, {"groupId": "OG001", "value": "-5.7", "spread": "11.41"}, {"groupId": "OG002", "value": "-3.7", "spread": "14.22"}, {"groupId": "OG003", "value": "-0.2", "spread": "6.79"}, {"groupId": "OG004", "value": "-3.0", "spread": "4.12"}]}]}]}, {"type": "PRIMARY", "title": "Laboratory Parameters - Lipid Profile - Participants With Clinically Significant Findings", "description": "Number of participants with clinically significant changes from baseline in laboratory parameters (lipid profile) and the relationship to PB1046 compared to placebo", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Eight weeks starting one week before first dose (Baseline and at Week 8).", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of placebo comparator, 0.9% NaCl.\n\nPB1046 Injection: Four weekly subcutaneous injections of placebo comparator."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "0"}, {"groupId": "OG004", "value": "0"}]}]}]}, {"type": "PRIMARY", "title": "Vital Signs - Systolic Blood Pressure", "description": "Changes from baseline in vital signs (systolic blood pressure) and the relationship to PB1046 compared to placebo.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Day 0 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.4", "spread": "10.88"}, {"groupId": "OG001", "value": "-6.2", "spread": "19.89"}, {"groupId": "OG002", "value": "3.1", "spread": "8.17"}, {"groupId": "OG003", "value": "-2.6", "spread": "13.43"}, {"groupId": "OG004", "value": "4.6", "spread": "17.41"}]}]}, {"title": "Day 0 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.9", "spread": "7.17"}, {"groupId": "OG001", "value": "-2.6", "spread": "14.06"}, {"groupId": "OG002", "value": "1.3", "spread": "6.52"}, {"groupId": "OG003", "value": "-8.7", "spread": "6.24"}, {"groupId": "OG004", "value": "3.4", "spread": "11.57"}]}]}, {"title": "Day 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "2.87"}, {"groupId": "OG001", "value": "-5.8", "spread": "14.89"}, {"groupId": "OG002", "value": "-2.3", "spread": "4.79"}, {"groupId": "OG003", "value": "-15.4", "spread": "18.17"}, {"groupId": "OG004", "value": "-7.1", "spread": "14.59"}]}]}, {"title": "Day 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "7.07"}, {"groupId": "OG001", "value": "-4.4", "spread": "13.45"}, {"groupId": "OG002", "value": "-7.2", "spread": "7.98"}, {"groupId": "OG003", "value": "-8.9", "spread": "12.63"}, {"groupId": "OG004", "value": "-2.9", "spread": "23.54"}]}]}, {"title": "Day 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.7", "spread": "8.25"}, {"groupId": "OG001", "value": "1.8", "spread": "24.86"}, {"groupId": "OG002", "value": "-8.9", "spread": "9.08"}, {"groupId": "OG003", "value": "-17.8", "spread": "18.09"}, {"groupId": "OG004", "value": "-1.8", "spread": "16.75"}]}]}, {"title": "Day 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.4", "spread": "11.42"}, {"groupId": "OG001", "value": "-4.6", "spread": "23.37"}, {"groupId": "OG002", "value": "1.5", "spread": "8.57"}, {"groupId": "OG003", "value": "-11.7", "spread": "20.19"}, {"groupId": "OG004", "value": "1.3", "spread": "10.44"}]}]}, {"title": "Day 7 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-6.9", "spread": "2.22"}, {"groupId": "OG001", "value": "-9.4", "spread": "11.47"}, {"groupId": "OG002", "value": "-5.9", "spread": "13.47"}, {"groupId": "OG003", "value": "-11.7", "spread": "3.78"}, {"groupId": "OG004", "value": "-0.3", "spread": "10.73"}]}]}, {"title": "Day 14 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.3", "spread": "9.60"}, {"groupId": "OG001", "value": "-8.0", "spread": "14.73"}, {"groupId": "OG002", "value": "-1.6", "spread": "9.32"}, {"groupId": "OG003", "value": "-8.8", "spread": "14.62"}, {"groupId": "OG004", "value": "-3.0", "spread": "17.71"}]}]}, {"title": "Day 21 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.0", "spread": "6.57"}, {"groupId": "OG001", "value": "-8.4", "spread": "9.37"}, {"groupId": "OG002", "value": "-1.6", "spread": "9.32"}, {"groupId": "OG003", "value": "-8.8", "spread": "14.62"}, {"groupId": "OG004", "value": "-5.1", "spread": "13.04"}]}]}, {"title": "Day 21 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.9", "spread": "4.40"}, {"groupId": "OG001", "value": "-14.1", "spread": "9.15"}, {"groupId": "OG002", "value": "-4.0", "spread": "10.00"}, {"groupId": "OG003", "value": "-12.8", "spread": "15.89"}, {"groupId": "OG004", "value": "-3.0", "spread": "9.00"}]}]}, {"title": "Day 21 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-7.9", "spread": "4.40"}, {"groupId": "OG001", "value": "-14.1", "spread": "9.15"}, {"groupId": "OG002", "value": "-4.0", "spread": "10.00"}, {"groupId": "OG003", "value": "-12.8", "spread": "15.89"}, {"groupId": "OG004", "value": "-3.0", "spread": "9.00"}]}]}, {"title": "Day 22", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.0", "spread": "4.81"}, {"groupId": "OG001", "value": "-10.6", "spread": "18.27"}, {"groupId": "OG002", "value": "-9.4", "spread": "10.46"}, {"groupId": "OG003", "value": "-20.8", "spread": "17.19"}, {"groupId": "OG004", "value": "-3.4", "spread": "13.67"}]}]}, {"title": "Day 23", "categories": [{"measurements": [{"groupId": "OG000", "value": "-9.2", "spread": "12.16"}, {"groupId": "OG001", "value": "-4.7", "spread": "9.18"}, {"groupId": "OG002", "value": "-9.2", "spread": "11.77"}, {"groupId": "OG003", "value": "-8.0", "spread": "4.33"}, {"groupId": "OG004", "value": "-0.8", "spread": "11.38"}]}]}, {"title": "Day 24", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.9", "spread": "5.50"}, {"groupId": "OG001", "value": "-1.9", "spread": "9.19"}, {"groupId": "OG002", "value": "-1.0", "spread": "12.16"}, {"groupId": "OG003", "value": "-21.6", "spread": "29.51"}, {"groupId": "OG004", "value": "2.0", "spread": "20.23"}]}]}, {"title": "Day 26", "categories": [{"measurements": [{"groupId": "OG000", "value": "-8.7", "spread": "8.02"}, {"groupId": "OG001", "value": "-11.6", "spread": "8.41"}, {"groupId": "OG002", "value": "-11.4", "spread": "5.05"}, {"groupId": "OG003", "value": "-9.6", "spread": "19.51"}, {"groupId": "OG004", "value": "-4.5", "spread": "14.75"}]}]}, {"title": "Day 28", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "spread": "9.83"}, {"groupId": "OG001", "value": "-9.4", "spread": "13.93"}, {"groupId": "OG002", "value": "-8.1", "spread": "12.89"}, {"groupId": "OG003", "value": "-6.3", "spread": "20.28"}, {"groupId": "OG004", "value": "-1.2", "spread": "21.19"}]}]}, {"title": "Day 29", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.2", "spread": "12.05"}, {"groupId": "OG001", "value": "-7.4", "spread": "15.88"}, {"groupId": "OG002", "value": "-4.6", "spread": "12.30"}, {"groupId": "OG003", "value": "-8.9", "spread": "7.54"}, {"groupId": "OG004", "value": "-3.6", "spread": "21.02"}]}]}, {"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.8", "spread": "8.00"}, {"groupId": "OG001", "value": "-7.6", "spread": "18.85"}, {"groupId": "OG002", "value": "-5.9", "spread": "9.96"}, {"groupId": "OG003", "value": "-11.0", "spread": "15.48"}, {"groupId": "OG004", "value": "-4.5", "spread": "25.36"}]}]}, {"title": "Day 31", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "1.35"}, {"groupId": "OG001", "value": "-10.4", "spread": "17.18"}, {"groupId": "OG002", "value": "-9.3", "spread": "9.45"}, {"groupId": "OG003", "value": "-12.8", "spread": "14.83"}, {"groupId": "OG004", "value": "-0.2", "spread": "13.98"}]}]}, {"title": "Day 49", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.1", "spread": "14.95"}, {"groupId": "OG001", "value": "-6.9", "spread": "12.42"}, {"groupId": "OG002", "value": "-10.2", "spread": "11.97"}, {"groupId": "OG003", "value": "-16.8", "spread": "22.45"}, {"groupId": "OG004", "value": "-3.0", "spread": "14.78"}]}]}]}, {"type": "PRIMARY", "title": "Vital Signs - Heart Rate", "description": "Changes from baseline in vital signs (heart rate) and the relationship to PB1046 compared to placebo.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Beats/min", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Day 0 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "4.55"}, {"groupId": "OG001", "value": "-2.1", "spread": "6.23"}, {"groupId": "OG002", "value": "-2.5", "spread": "9.66"}, {"groupId": "OG003", "value": "2.3", "spread": "3.64"}, {"groupId": "OG004", "value": "-3.0", "spread": "5.79"}]}]}, {"title": "Day 0 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.7", "spread": "6.49"}, {"groupId": "OG001", "value": "-2.4", "spread": "5.39"}, {"groupId": "OG002", "value": "0.0", "spread": "8.67"}, {"groupId": "OG003", "value": "1.2", "spread": "2.83"}, {"groupId": "OG004", "value": "3.0", "spread": "9.64"}]}]}, {"title": "Day 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "4.1", "spread": "3.38"}, {"groupId": "OG002", "value": "-1.6", "spread": "9.66"}, {"groupId": "OG003", "value": "4.1", "spread": "5.53"}, {"groupId": "OG004", "value": "3.2", "spread": "4.09"}]}]}, {"title": "Day 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.7", "spread": "2.31"}, {"groupId": "OG001", "value": "-6.0", "spread": "15.58"}, {"groupId": "OG002", "value": "-3.3", "spread": "8.73"}, {"groupId": "OG003", "value": "2.6", "spread": "3.83"}, {"groupId": "OG004", "value": "4.5", "spread": "8.66"}]}]}, {"title": "Day 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.8", "spread": "1.35"}, {"groupId": "OG001", "value": "-0.8", "spread": "5.51"}, {"groupId": "OG002", "value": "-2.2", "spread": "4.24"}, {"groupId": "OG003", "value": "1.4", "spread": "5.86"}, {"groupId": "OG004", "value": "-.04", "spread": "6.82"}]}]}, {"title": "Day 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "3.67"}, {"groupId": "OG001", "value": "-2.9", "spread": "5.06"}, {"groupId": "OG002", "value": "-3.2", "spread": "9.09"}, {"groupId": "OG003", "value": "2.9", "spread": "5.85"}, {"groupId": "OG004", "value": "3.1", "spread": "8.62"}]}]}, {"title": "Day 7 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.6", "spread": "2.67"}, {"groupId": "OG001", "value": "-0.4", "spread": "5.74"}, {"groupId": "OG002", "value": "-4.5", "spread": "6.05"}, {"groupId": "OG003", "value": "1.6", "spread": "1.83"}, {"groupId": "OG004", "value": "-1.7", "spread": "8.01"}]}]}, {"title": "Day 14 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.4", "spread": "2.14"}, {"groupId": "OG001", "value": "-3.7", "spread": "6.26"}, {"groupId": "OG002", "value": "-0.6", "spread": "2.65"}, {"groupId": "OG003", "value": "0.5", "spread": "1.29"}, {"groupId": "OG004", "value": "-1.9", "spread": "7.16"}]}]}, {"title": "Day 21 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.6", "spread": "4.67"}, {"groupId": "OG001", "value": "-2.6", "spread": "7.62"}, {"groupId": "OG002", "value": "-2.7", "spread": "2.72"}, {"groupId": "OG003", "value": "0.2", "spread": "0.96"}, {"groupId": "OG004", "value": "-4.7", "spread": "5.84"}]}]}, {"title": "Day 21 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.6", "spread": "4.67"}, {"groupId": "OG001", "value": "-1.4", "spread": "7.49"}, {"groupId": "OG002", "value": "0.9", "spread": "2.23"}, {"groupId": "OG003", "value": "1.2", "spread": "1.00"}, {"groupId": "OG004", "value": "-4.7", "spread": "5.84"}]}]}, {"title": "Day 21 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "8.3", "spread": "4.93"}, {"groupId": "OG001", "value": "3.6", "spread": "3.62"}, {"groupId": "OG002", "value": "-0.9", "spread": "3.51"}, {"groupId": "OG003", "value": "0.9", "spread": "1.83"}, {"groupId": "OG004", "value": "0.2", "spread": "10.92"}]}]}, {"title": "Day 22", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.2", "spread": "3.02"}, {"groupId": "OG001", "value": "-3.3", "spread": "10.02"}, {"groupId": "OG002", "value": "0.3", "spread": "5.37"}, {"groupId": "OG003", "value": "0.4", "spread": "1.07"}, {"groupId": "OG004", "value": "0.3", "spread": "8.10"}]}]}, {"title": "Day 23", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.8", "spread": "1.68"}, {"groupId": "OG001", "value": "-2.4", "spread": "13.10"}, {"groupId": "OG002", "value": "-2.5", "spread": "5.92"}, {"groupId": "OG003", "value": "1.4", "spread": "1.32"}, {"groupId": "OG004", "value": "-0.9", "spread": "10.13"}]}]}, {"title": "Day 24", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.4", "spread": "3.15"}, {"groupId": "OG001", "value": "-0.8", "spread": "8.52"}, {"groupId": "OG002", "value": "-2.1", "spread": "4.65"}, {"groupId": "OG003", "value": "1.4", "spread": "1.40"}, {"groupId": "OG004", "value": "-1.5", "spread": "7.49"}]}]}, {"title": "Day 26", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.4", "spread": "3.91"}, {"groupId": "OG001", "value": "-2.2", "spread": "10.56"}, {"groupId": "OG002", "value": "-1.6", "spread": "6.97"}, {"groupId": "OG003", "value": "0.4", "spread": "1.13"}, {"groupId": "OG004", "value": "-0.8", "spread": "7.77"}]}]}, {"title": "Day 28", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "8.09"}, {"groupId": "OG001", "value": "-0.5", "spread": "11.09"}, {"groupId": "OG002", "value": "-1.5", "spread": "2.10"}, {"groupId": "OG003", "value": "0.2", "spread": "1.97"}, {"groupId": "OG004", "value": "-2.8", "spread": "7.52"}]}]}, {"title": "Day 29", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "3.18"}, {"groupId": "OG001", "value": "-2.5", "spread": "8.62"}, {"groupId": "OG002", "value": "-2.1", "spread": "9.99"}, {"groupId": "OG003", "value": "2.9", "spread": "7.47"}, {"groupId": "OG004", "value": "-1.1", "spread": "6.84"}]}]}, {"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.4", "spread": "2.50"}, {"groupId": "OG001", "value": "-3.9", "spread": "11.54"}, {"groupId": "OG002", "value": "-3.6", "spread": "7.61"}, {"groupId": "OG003", "value": "0.8", "spread": "1.67"}, {"groupId": "OG004", "value": "1.7", "spread": "8.13"}]}]}, {"title": "Day 31", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "3.10"}, {"groupId": "OG001", "value": "-4.9", "spread": "8.27"}, {"groupId": "OG002", "value": "-1.4", "spread": "4.96"}, {"groupId": "OG003", "value": "-1.6", "spread": "1.95"}, {"groupId": "OG004", "value": "0.5", "spread": "7.43"}]}]}, {"title": "Day 49", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.0", "spread": "2.33"}, {"groupId": "OG001", "value": "-2.9", "spread": "14.19"}, {"groupId": "OG002", "value": "-2.3", "spread": "4.67"}, {"groupId": "OG003", "value": "1.8", "spread": "4.84"}, {"groupId": "OG004", "value": "-2.4", "spread": "5.70"}]}]}]}, {"type": "PRIMARY", "title": "Vital Signs - Temperature", "description": "Changes from baseline in vital signs (temperature) and the relationship to PB1046 compared to placebo.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Celsius", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Day 0 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "0.10"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.35"}, {"groupId": "OG002", "value": "0.0", "spread": "0.34"}, {"groupId": "OG003", "value": "0.0", "spread": "0.33"}, {"groupId": "OG004", "value": "-0.1", "spread": "0.28"}]}]}, {"title": "Day 0 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.06"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.36"}, {"groupId": "OG002", "value": "0.0", "spread": "0.39"}, {"groupId": "OG003", "value": "0.1", "spread": "0.24"}, {"groupId": "OG004", "value": "0.2", "spread": "0.53"}]}]}, {"title": "Day 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.12"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.52"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.40"}, {"groupId": "OG003", "value": "0.3", "spread": "0.14"}, {"groupId": "OG004", "value": "0.2", "spread": "0.38"}]}]}, {"title": "Day 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.1", "spread": "2.06"}, {"groupId": "OG001", "value": "-0.5", "spread": "0.65"}, {"groupId": "OG002", "value": "-0.0", "spread": "0.45"}, {"groupId": "OG003", "value": "0.1", "spread": "0.23"}, {"groupId": "OG004", "value": "-0.1", "spread": "0.59"}]}]}, {"title": "Day 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.2", "spread": "2.20"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.46"}, {"groupId": "OG002", "value": "0.0", "spread": "0.49"}, {"groupId": "OG003", "value": "0.1", "spread": "0.39"}, {"groupId": "OG004", "value": "0.0", "spread": "0.66"}]}]}, {"title": "Day 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.36"}, {"groupId": "OG002", "value": "0.1", "spread": "0.26"}, {"groupId": "OG003", "value": "0.1", "spread": "0.39"}, {"groupId": "OG004", "value": "0.0", "spread": "0.52"}]}]}, {"title": "Day 7 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "0.06"}, {"groupId": "OG001", "value": "0.0", "spread": "1.22"}, {"groupId": "OG002", "value": "0.1", "spread": "0.27"}, {"groupId": "OG003", "value": "0.0", "spread": "0.25"}, {"groupId": "OG004", "value": "0.1", "spread": "0.37"}]}]}, {"title": "Day 14 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.2", "spread": "0.49"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.39"}, {"groupId": "OG002", "value": "0.2", "spread": "0.27"}, {"groupId": "OG003", "value": "0.1", "spread": "0.29"}, {"groupId": "OG004", "value": "0.1", "spread": "0.48"}]}]}, {"title": "Day 21 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.36"}, {"groupId": "OG001", "value": "0.1", "spread": "0.48"}, {"groupId": "OG002", "value": "0.0", "spread": "0.42"}, {"groupId": "OG003", "value": "0.1", "spread": "0.34"}, {"groupId": "OG004", "value": "0.1", "spread": "0.50"}]}]}, {"title": "Day 21 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.23"}, {"groupId": "OG001", "value": "-0.2", "spread": "0.29"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.39"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.36"}, {"groupId": "OG004", "value": "0.0", "spread": "0.55"}]}]}, {"title": "Day 22", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.31"}, {"groupId": "OG001", "value": "0.1", "spread": "0.24"}, {"groupId": "OG002", "value": "0.2", "spread": "0.24"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.22"}, {"groupId": "OG004", "value": "0.0", "spread": "0.49"}]}]}, {"title": "Day 23", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.25"}, {"groupId": "OG001", "value": "0.2", "spread": "0.25"}, {"groupId": "OG002", "value": "0.1", "spread": "0.23"}, {"groupId": "OG003", "value": "0.1", "spread": "0.26"}, {"groupId": "OG004", "value": "0.1", "spread": "0.48"}]}]}, {"title": "Day 24", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.40"}, {"groupId": "OG001", "value": "0.1", "spread": "0.28"}, {"groupId": "OG002", "value": "0.2", "spread": "0.30"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.51"}, {"groupId": "OG004", "value": "0.1", "spread": "0.47"}]}]}, {"title": "Day 26", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.2", "spread": "0.15"}, {"groupId": "OG001", "value": "0.0", "spread": "0.66"}, {"groupId": "OG002", "value": "0.1", "spread": "0.34"}, {"groupId": "OG003", "value": "-0.1", "spread": "0.15"}, {"groupId": "OG004", "value": "0.0", "spread": "0.44"}]}]}, {"title": "Day 28", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.6", "spread": "1.42"}, {"groupId": "OG001", "value": "0.2", "spread": "0.53"}, {"groupId": "OG002", "value": "-0.2", "spread": "0.43"}, {"groupId": "OG003", "value": "0.3", "spread": "0.30"}, {"groupId": "OG004", "value": "0.0", "spread": "0.44"}]}]}, {"title": "Day 29", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.21"}, {"groupId": "OG001", "value": "-0.3", "spread": "0.69"}, {"groupId": "OG002", "value": "0.0", "spread": "0.40"}, {"groupId": "OG003", "value": "0.1", "spread": "0.38"}, {"groupId": "OG004", "value": "0.1", "spread": "0.52"}]}]}, {"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.0", "spread": "1.91"}, {"groupId": "OG001", "value": "-0.1", "spread": "0.69"}, {"groupId": "OG002", "value": "0.1", "spread": "0.30"}, {"groupId": "OG003", "value": "0.0", "spread": "0.44"}, {"groupId": "OG004", "value": "0.1", "spread": "0.51"}]}]}, {"title": "Day 31", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.3", "spread": "0.25"}, {"groupId": "OG001", "value": "0.1", "spread": "0.57"}, {"groupId": "OG002", "value": "0.1", "spread": "0.37"}, {"groupId": "OG003", "value": "-0.2", "spread": "0.29"}, {"groupId": "OG004", "value": "-0.1", "spread": "0.73"}]}]}, {"title": "Day 49", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.36"}, {"groupId": "OG001", "value": "0.1", "spread": "0.55"}, {"groupId": "OG002", "value": "0.1", "spread": "0.42"}, {"groupId": "OG003", "value": "0.0", "spread": "0.43"}, {"groupId": "OG004", "value": "8.7", "spread": "22.71"}]}]}]}, {"type": "PRIMARY", "title": "Vital Signs - Respiratory Rate", "description": "Changes from baseline in vital signs (respiratory rate) and the relationship to PB1046 compared to placebo.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Breaths/min", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Day 0 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "0.3", "spread": "1.51"}, {"groupId": "OG002", "value": "0.9", "spread": "1.57"}, {"groupId": "OG003", "value": "-0.3", "spread": "1.51"}, {"groupId": "OG004", "value": "0.4", "spread": "1.51"}]}]}, {"title": "Day 0 3hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.3", "spread": "2.31"}, {"groupId": "OG001", "value": "0.7", "spread": "2.07"}, {"groupId": "OG002", "value": "0.0", "spread": "1.15"}, {"groupId": "OG003", "value": "0.0", "spread": "1.26"}, {"groupId": "OG004", "value": "0.8", "spread": "1.83"}]}]}, {"title": "Day 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "0.3", "spread": "2.25"}, {"groupId": "OG002", "value": "-0.6", "spread": "1.51"}, {"groupId": "OG003", "value": "-1.0", "spread": "1.10"}, {"groupId": "OG004", "value": "0.3", "spread": "1.25"}]}]}, {"title": "Day 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "1.00"}, {"groupId": "OG001", "value": "0.3", "spread": "1.77"}, {"groupId": "OG002", "value": "0.3", "spread": "0.76"}, {"groupId": "OG003", "value": "-0.3", "spread": "1.51"}, {"groupId": "OG004", "value": "-0.1", "spread": "1.81"}]}]}, {"title": "Day 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "-1.2", "spread": "2.15"}, {"groupId": "OG002", "value": "0.3", "spread": "2.14"}, {"groupId": "OG003", "value": "0.3", "spread": "1.51"}, {"groupId": "OG004", "value": "0.1", "spread": "1.07"}]}]}, {"title": "Day 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "0.00"}, {"groupId": "OG001", "value": "0.4", "spread": "1.75"}, {"groupId": "OG002", "value": "-0.1", "spread": "0.90"}, {"groupId": "OG003", "value": "0.3", "spread": "0.082"}, {"groupId": "OG004", "value": "0.6", "spread": "1.62"}]}]}, {"title": "Day 21 1hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "1.15"}, {"groupId": "OG001", "value": "0.7", "spread": "2.07"}, {"groupId": "OG002", "value": "-0.3", "spread": "1.51"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "-0.4", "spread": "3.05"}]}]}, {"title": "Day 21 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "2.00"}, {"groupId": "OG001", "value": "0.0", "spread": "0.00"}, {"groupId": "OG002", "value": "-0.3", "spread": "1.97"}, {"groupId": "OG003", "value": "0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "0.4", "spread": "2.44"}]}]}, {"title": "Day 21 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.3", "spread": "1.15"}, {"groupId": "OG001", "value": "1.0", "spread": "3.52"}, {"groupId": "OG002", "value": "0.7", "spread": "1.63"}, {"groupId": "OG003", "value": "0.0", "spread": "0.00"}, {"groupId": "OG004", "value": "0.6", "spread": "1.81"}]}]}, {"title": "Day 22", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "2.00"}, {"groupId": "OG001", "value": "1.5", "spread": "2.51"}, {"groupId": "OG002", "value": "0.0", "spread": "2.19"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "0.2", "spread": "2.28"}]}]}, {"title": "Day 23", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "2.00"}, {"groupId": "OG001", "value": "0.8", "spread": "1.60"}, {"groupId": "OG002", "value": "-1.0", "spread": "2.10"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "-0.4", "spread": "3.15"}]}]}, {"title": "Day 24", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "1.2", "spread": "2.56"}, {"groupId": "OG002", "value": "0.0", "spread": "1.79"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "0.2", "spread": "1.56"}]}]}, {"title": "Day 26", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "1.2", "spread": "2.56"}, {"groupId": "OG002", "value": "0.0", "spread": "1.79"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "0.3", "spread": "1.89"}]}]}, {"title": "Day 28", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.0", "spread": "2.00"}, {"groupId": "OG001", "value": "1.2", "spread": "3.37"}, {"groupId": "OG002", "value": "0.3", "spread": "1.97"}, {"groupId": "OG003", "value": "-0.5", "spread": "1.00"}, {"groupId": "OG004", "value": "0.6", "spread": "2.44"}]}]}, {"title": "Day 29", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "1.7", "spread": "3.44"}, {"groupId": "OG002", "value": "-0.3", "spread": "1.51"}, {"groupId": "OG003", "value": "-1.0", "spread": "1.15"}, {"groupId": "OG004", "value": "-0.3", "spread": "2.06"}]}]}, {"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "1.3", "spread": "2.42"}, {"groupId": "OG002", "value": "0.0", "spread": "1.26"}, {"groupId": "OG003", "value": "-1.0", "spread": "1.15"}, {"groupId": "OG004", "value": "0.3", "spread": "2.43"}]}]}, {"title": "Day 49", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.7", "spread": "1.15"}, {"groupId": "OG001", "value": "1.2", "spread": "2.40"}, {"groupId": "OG002", "value": "0.7", "spread": "1.03"}, {"groupId": "OG003", "value": "0.0", "spread": "1.26"}, {"groupId": "OG004", "value": "-0.3", "spread": "1.38"}]}]}]}, {"type": "PRIMARY", "title": "Vital Signs - Diastolic Blood Pressure", "description": "Changes from baseline in vital signs (systolic blood pressure) and the relationship to PB1046 compared to placebo.", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "Baseline, Day 0, Day 1, 2, 3, 5, 7, 14, 21, 22, 23, 24, 26, 28, 29, 30, 31, and 49.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"title": "Day 0 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.3", "spread": "3.38"}, {"groupId": "OG001", "value": "-5.7", "spread": "13.53"}, {"groupId": "OG002", "value": "-2.5", "spread": "10.64"}, {"groupId": "OG003", "value": "-1.4", "spread": "5.68"}, {"groupId": "OG004", "value": "7.8", "spread": "9.34"}]}]}, {"title": "Day 0 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.1", "spread": "2.50"}, {"groupId": "OG001", "value": "-3.1", "spread": "11.89"}, {"groupId": "OG002", "value": "-4.4", "spread": "11.10"}, {"groupId": "OG003", "value": "-3.9", "spread": "4.08"}, {"groupId": "OG004", "value": "2.6", "spread": "3.50"}]}]}, {"title": "Day 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.7", "spread": "1.76"}, {"groupId": "OG001", "value": "-1.9", "spread": "9.52"}, {"groupId": "OG002", "value": "-1.5", "spread": "7.77"}, {"groupId": "OG003", "value": "-9.5", "spread": "11.69"}, {"groupId": "OG004", "value": "3.8", "spread": "7.99"}]}]}, {"title": "Day 2", "categories": [{"measurements": [{"groupId": "OG000", "value": "-0.9", "spread": "5.09"}, {"groupId": "OG001", "value": "-1.7", "spread": "7.48"}, {"groupId": "OG002", "value": "-3.0", "spread": "9.41"}, {"groupId": "OG003", "value": "-5.7", "spread": "7.20"}, {"groupId": "OG004", "value": "3.6", "spread": "10.18"}]}]}, {"title": "Day 3", "categories": [{"measurements": [{"groupId": "OG000", "value": "-5.8", "spread": "2.17"}, {"groupId": "OG001", "value": "0.1", "spread": "10.36"}, {"groupId": "OG002", "value": "-2.0", "spread": "8.14"}, {"groupId": "OG003", "value": "-11.3", "spread": "7.33"}, {"groupId": "OG004", "value": "2.8", "spread": "7.93"}]}]}, {"title": "Day 5", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.1", "spread": "7.88"}, {"groupId": "OG001", "value": "1.3", "spread": "9.01"}, {"groupId": "OG002", "value": "-1.1", "spread": "6.61"}, {"groupId": "OG003", "value": "-6.9", "spread": "12.32"}, {"groupId": "OG004", "value": "1.2", "spread": "5.82"}]}]}, {"title": "Day 7 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.2", "spread": "8.60"}, {"groupId": "OG001", "value": "-2.5", "spread": "6.88"}, {"groupId": "OG002", "value": "-1.4", "spread": "12.28"}, {"groupId": "OG003", "value": "-2.5", "spread": "15.60"}, {"groupId": "OG004", "value": "3.6", "spread": "6.05"}]}]}, {"title": "Day 14 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "3.1", "spread": "4.44"}, {"groupId": "OG001", "value": "-2.9", "spread": "7.07"}, {"groupId": "OG002", "value": "-0.2", "spread": "7.73"}, {"groupId": "OG003", "value": "-4.7", "spread": "7.88"}, {"groupId": "OG004", "value": "6.0", "spread": "6.28"}]}]}, {"title": "Day 21 pre", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.7", "spread": "2.40"}, {"groupId": "OG001", "value": "-1.3", "spread": "8.50"}, {"groupId": "OG002", "value": "2.1", "spread": "10.83"}, {"groupId": "OG003", "value": "-5.8", "spread": "5.91"}, {"groupId": "OG004", "value": "4.2", "spread": "7.23"}]}]}, {"title": "Day 21 1 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-3.4", "spread": "1.26"}, {"groupId": "OG001", "value": "-4.9", "spread": "11.98"}, {"groupId": "OG002", "value": "-2.2", "spread": "9.70"}, {"groupId": "OG003", "value": "-9.8", "spread": "6.43"}, {"groupId": "OG004", "value": "2.2", "spread": "8.35"}]}]}, {"title": "Day 21 3 hr", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "3.91"}, {"groupId": "OG001", "value": "-7.3", "spread": "6.34"}, {"groupId": "OG002", "value": "-0.9", "spread": "10.82"}, {"groupId": "OG003", "value": "-9.8", "spread": "8.03"}, {"groupId": "OG004", "value": "4.3", "spread": "6.82"}]}]}, {"title": "Day 22", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "4.40"}, {"groupId": "OG001", "value": "-6.1", "spread": "10.52"}, {"groupId": "OG002", "value": "-2.2", "spread": "9.80"}, {"groupId": "OG003", "value": "-10.8", "spread": "8.63"}, {"groupId": "OG004", "value": "1.8", "spread": "9.89"}]}]}, {"title": "Day 23", "categories": [{"measurements": [{"groupId": "OG000", "value": "-2.1", "spread": "5.00"}, {"groupId": "OG001", "value": "-2.1", "spread": "8.88"}, {"groupId": "OG002", "value": "-3.2", "spread": "12.10"}, {"groupId": "OG003", "value": "-6.1", "spread": "5.39"}, {"groupId": "OG004", "value": "4.5", "spread": "7.81"}]}]}, {"title": "Day 24", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.0", "spread": "2.91"}, {"groupId": "OG001", "value": "1.3", "spread": "7.61"}, {"groupId": "OG002", "value": "1.7", "spread": "9.05"}, {"groupId": "OG003", "value": "-12.8", "spread": "14.55"}, {"groupId": "OG004", "value": "3.0", "spread": "10.50"}]}]}, {"title": "Day 26", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "7.13"}, {"groupId": "OG001", "value": "-6.1", "spread": "9.86"}, {"groupId": "OG002", "value": "-3.2", "spread": "10.03"}, {"groupId": "OG003", "value": "-6.4", "spread": "6.58"}, {"groupId": "OG004", "value": "0.8", "spread": "6.74"}]}]}, {"title": "Day 28", "categories": [{"measurements": [{"groupId": "OG000", "value": "-1.4", "spread": "1.58"}, {"groupId": "OG001", "value": "-1.4", "spread": "9.43"}, {"groupId": "OG002", "value": "-0.2", "spread": "8.64"}, {"groupId": "OG003", "value": "-8.3", "spread": "12.66"}, {"groupId": "OG004", "value": "3.7", "spread": "10.41"}]}]}, {"title": "Day 29", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.6", "spread": "7.34"}, {"groupId": "OG001", "value": "-2.0", "spread": "6.72"}, {"groupId": "OG002", "value": "-1.5", "spread": "9.98"}, {"groupId": "OG003", "value": "-3.7", "spread": "9.64"}, {"groupId": "OG004", "value": "2.9", "spread": "6.22"}]}]}, {"title": "Day 30", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.8", "spread": "2.52"}, {"groupId": "OG001", "value": "-2.8", "spread": "7.92"}, {"groupId": "OG002", "value": "-1.9", "spread": "11.77"}, {"groupId": "OG003", "value": "-8.8", "spread": "5.47"}, {"groupId": "OG004", "value": "3.6", "spread": "9.02"}]}]}, {"title": "Day 31", "categories": [{"measurements": [{"groupId": "OG000", "value": "-4.3", "spread": "4.04"}, {"groupId": "OG001", "value": "-4.6", "spread": "10.98"}, {"groupId": "OG002", "value": "0.3", "spread": "10.02"}, {"groupId": "OG003", "value": "-8.9", "spread": "6.10"}, {"groupId": "OG004", "value": "3.9", "spread": "6.99"}]}]}, {"title": "Day 49", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.6", "spread": "2.22"}, {"groupId": "OG001", "value": "-3.1", "spread": "7.86"}, {"groupId": "OG002", "value": "-5.3", "spread": "11.08"}, {"groupId": "OG003", "value": "-5.0", "spread": "10.27"}, {"groupId": "OG004", "value": "5.1", "spread": "4.89"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Area Under the Curve Over the Dosing Interval [AUC(0-t)]", "description": "Comparison of dose exposures \\[AUC(0-t)\\] during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "h*ng/mL", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "5791.391", "spread": "1639.3"}, {"groupId": "OG001", "value": "12382.716", "spread": "4869.3"}, {"groupId": "OG002", "value": "14789.912", "spread": "4269.7"}, {"groupId": "OG003", "value": "25555.798", "spread": "11248.6"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "7440.721", "spread": "6183.8"}, {"groupId": "OG001", "value": "19007.517", "spread": "12655.5"}, {"groupId": "OG002", "value": "16689.657", "spread": "7313.0"}, {"groupId": "OG003", "value": "21997.727", "spread": "7709.6"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Maximum Serum Concentration (Cmax)", "description": "Comparison of dose exposures (Cmax) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "ng/mL", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "47.433", "spread": "17.3"}, {"groupId": "OG001", "value": "128.317", "spread": "64.1"}, {"groupId": "OG002", "value": "218.471", "spread": "106.3"}, {"groupId": "OG003", "value": "207.600", "spread": "112.3"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "53.600", "spread": "40.2"}, {"groupId": "OG001", "value": "233.450", "spread": "189.6"}, {"groupId": "OG002", "value": "211.967", "spread": "110.1"}, {"groupId": "OG003", "value": "239.000", "spread": "102.6"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Time to Cmax (Tmax)", "description": "Comparison of dose exposures (Tmax) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "hours", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "39.533", "spread": "14.1"}, {"groupId": "OG001", "value": "57.594", "spread": "54.0"}, {"groupId": "OG002", "value": "27.645", "spread": "15.7"}, {"groupId": "OG003", "value": "55.578", "spread": "35.8"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "32.028", "spread": "13.7"}, {"groupId": "OG001", "value": "32.042", "spread": "12.2"}, {"groupId": "OG002", "value": "36.153", "spread": "13.6"}, {"groupId": "OG003", "value": "35.804", "spread": "13.9"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Elimination Rate Constant (Lambda z)", "description": "Comparison of dose exposures (lambda z) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "1/hour", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.015", "spread": "0.0"}, {"groupId": "OG001", "value": "0.018", "spread": "0.0"}, {"groupId": "OG002", "value": "0.017", "spread": "0.0"}, {"groupId": "OG003", "value": "0.010", "spread": "0.0"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "0.015", "spread": "0.0"}, {"groupId": "OG001", "value": "0.026", "spread": "0.0"}, {"groupId": "OG002", "value": "0.021", "spread": "0.0"}, {"groupId": "OG003", "value": "0.019", "spread": "0.0"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Elimination Half-life (t\u00bd)", "description": "Comparison of dose exposures (t\u00bd) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "hours", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "45.787", "spread": "4.7"}, {"groupId": "OG001", "value": "40.806", "spread": "7.8"}, {"groupId": "OG002", "value": "54.735", "spread": "35.8"}, {"groupId": "OG003", "value": "103.951", "spread": "94.6"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "78.382", "spread": "69.3"}, {"groupId": "OG001", "value": "28.333", "spread": "6.5"}, {"groupId": "OG002", "value": "34.602", "spread": "8.5"}, {"groupId": "OG003", "value": "44.902", "spread": "28.5"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Clearance (CL/F), Uncorrected for Bioavailability", "description": "Comparison of dose exposures (CL/F) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mL/h/kg", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "31.992", "spread": "10.1"}, {"groupId": "OG001", "value": "33.145", "spread": "11.8"}, {"groupId": "OG002", "value": "37.376", "spread": "8.2"}, {"groupId": "OG003", "value": "36.067", "spread": "15.0"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "26.981", "spread": "16.2"}, {"groupId": "OG001", "value": "28.443", "spread": "16.7"}, {"groupId": "OG002", "value": "39.940", "spread": "17.7"}, {"groupId": "OG003", "value": "49.220", "spread": "11.3"}]}]}]}, {"type": "SECONDARY", "title": "Pharmacokinetic Profile - Volume of Distribution (Vz/F), Uncorrected for Bioavailability (F)", "description": "Comparison of dose exposures (Vz/F) during once weekly administration of various doses of PB1046", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population. Only subjects with sufficient data analyzed.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "mL/kg", "timeFrame": "Pre-dose, Day 1 post-dose (1, 3, 24, 48, 72, 120 hours post-dose 1), Day 7, 14, 21 (1, 3, 24, 48, 72, 120 hours post-dose 4), Day 22, 23, 24, 26, 28, 29, 30, and 31.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "6"}, {"groupId": "OG003", "value": "4"}]}], "classes": [{"title": "Week 1", "categories": [{"measurements": [{"groupId": "OG000", "value": "2079.049", "spread": "451.5"}, {"groupId": "OG001", "value": "1955.795", "spread": "826.8"}, {"groupId": "OG002", "value": "2983.922", "spread": "1951.6"}, {"groupId": "OG003", "value": "4774.976", "spread": "3297.6"}]}]}, {"title": "Week 4", "categories": [{"measurements": [{"groupId": "OG000", "value": "3860.362", "spread": "4528.5"}, {"groupId": "OG001", "value": "1246.900", "spread": "979.1"}, {"groupId": "OG002", "value": "2122.745", "spread": "1412.1"}, {"groupId": "OG003", "value": "3401.624", "spread": "2650.3"}]}]}]}, {"type": "SECONDARY", "title": "Immunogenicity", "description": "Number of participants reporting positive immunogenicity (four-fold increase of pre-dose titer)", "populationDescription": "Safety/Intent-to-Treat/Per Protocol Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "subjects", "timeFrame": "Eleven weeks starting the first week of dosing.", "groups": [{"id": "OG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046."}, {"id": "OG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "7"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "7"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "2"}, {"groupId": "OG002", "value": "3"}, {"groupId": "OG003", "value": "6"}, {"groupId": "OG004", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "18 months", "eventGroups": [{"id": "EG000", "title": "PB1046 Injection, 0.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046.", "deathsNumAffected": 0, "deathsNumAtRisk": 3, "seriousNumAffected": 0, "seriousNumAtRisk": 3, "otherNumAffected": 3, "otherNumAtRisk": 3}, {"id": "EG001", "title": "PB1046 Injection, 0.4 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.4 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046.", "deathsNumAffected": 0, "deathsNumAtRisk": 6, "seriousNumAffected": 1, "seriousNumAtRisk": 6, "otherNumAffected": 6, "otherNumAtRisk": 6}, {"id": "EG002", "title": "PB1046 Injection, 0.6 mg/kg", "description": "Four weekly doses of PB1046 Injection, 0.6 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046.", "deathsNumAffected": 0, "deathsNumAtRisk": 7, "seriousNumAffected": 0, "seriousNumAtRisk": 7, "otherNumAffected": 7, "otherNumAtRisk": 7}, {"id": "EG003", "title": "PB1046 Injection, 1.2 mg/kg", "description": "Four weekly doses of PB1046 Injection, 1.2 mg/kg\n\nPB1046 Injection: Four weekly subcutaneous injections of PB1046.", "deathsNumAffected": 0, "deathsNumAtRisk": 6, "seriousNumAffected": 0, "seriousNumAtRisk": 6, "otherNumAffected": 6, "otherNumAtRisk": 6}, {"id": "EG004", "title": "Placebo Comparator", "description": "Four weekly doses of Placebo (0.9% NaCl) Injection\n\nPlacebo Injection: Four weekly subcutaneous injections of placebo.", "deathsNumAffected": 0, "deathsNumAtRisk": 7, "seriousNumAffected": 0, "seriousNumAtRisk": 7, "otherNumAffected": 0, "otherNumAtRisk": 7}], "seriousEvents": [{"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAtRisk": 3}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG002", "numAtRisk": 7}, {"groupId": "EG003", "numAtRisk": 6}, {"groupId": "EG004", "numAtRisk": 7}]}, {"term": "Blood creatinine increased", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAtRisk": 3}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG002", "numAtRisk": 7}, {"groupId": "EG003", "numAtRisk": 6}, {"groupId": "EG004", "numAtRisk": 7}]}, {"term": "White blood cell count", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAtRisk": 3}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG002", "numAtRisk": 7}, {"groupId": "EG003", "numAtRisk": 6}, {"groupId": "EG004", "numAtRisk": 7}]}], "otherEvents": [{"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Burning sensation", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 3, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Erythema", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Dizziness", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Flushing", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 2, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site erythema", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 20, "numAffected": 3, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 40, "numAffected": 6, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 34, "numAffected": 7, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 28, "numAffected": 6, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site induration", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site pain", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 9, "numAffected": 2, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 5, "numAffected": 2, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 10, "numAffected": 2, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 14, "numAffected": 6, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site pruritus", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 4, "numAffected": 2, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site swelling", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 4, "numAffected": 1, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 4, "numAffected": 2, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 5, "numAffected": 4, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 3, "numAffected": 2, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Injection site warmth", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}, {"term": "Malaise", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 3}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 6}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG003", "numEvents": 2, "numAffected": 1, "numAtRisk": 6}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "PIs are not permitted to publish or discuss trial results until 5 years after study completion."}, "pointOfContact": {"title": "Dr. John Lee, Chief Medical Officer", "organization": "PhaseBio", "email": "john.lee@PhaseBio.com", "phone": "6109816500"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2016-03-17", "uploadDate": "2022-03-17T10:01", "filename": "Prot_000.pdf", "size": 1727293}, {"typeAbbrev": "SAP", "hasProtocol": false, "hasSap": true, "hasIcf": false, "label": "Statistical Analysis Plan", "date": "2017-12-13", "uploadDate": "2022-03-17T09:51", "filename": "SAP_001.pdf", "size": 1199853}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M12307", "name": "Neoplasm Metastasis", "relevance": "LOW"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC04", "name": "Neoplasms"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC14", "name": "Heart and Blood Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000706508", "term": "VIP-ELP fusion molecule PB1046"}], "ancestors": [{"id": "D000014665", "term": "Vasodilator Agents"}], "browseLeaves": [{"id": "M111620", "name": "VIP-ELP fusion molecule PB1046", "asFound": "AAG", "relevance": "HIGH"}, {"id": "M17412", "name": "Vasodilator Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "VaDiAg", "name": "Vasodilator Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}